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Text S1: Supplementary methods 
Data collection 
For both datasets information was retrieved on date of notification, age, sex, local/foreign-born, 
ethnicity, time since entry (only applies to foreign-born immigrants and calculated as time between 
arrival in the UK/US and diagnosis of active TB), site of disease, HIV status, culture result and 
drug sensitivity. Certain information was only available/retrievable from one dataset: specific 
organs involved (Birmingham only) and state of notification (US only). 
 Routine HIV testing of patients diagnosed with active TB is highly inconsistent in the UK 
and this variable was inconsistently recorded in the Birmingham dataset. Therefore, we considered 
patients either as HIV positive (if recorded) or as negative/unknown (for all other individuals). 
 In the UK datasets, ethnicity was defined in line with the Office for National Statistics 
classification1 (five ethnic groups: White, Indian Subcontinent, Afro-Caribbean, Oriental/Other 
Asia, Other). Ethnicity in the US dataset was predefined into 5 categories (Hispanic or Latino, 
Non-Hispanic (NH) racial categories for White, American Indian or Alaska Native, Asian / Pacific 
Islander and Black/African American).  
We accounted for the independent effects of ethnicity and geographical origin by stratifying 
individuals into the following groups: Local-born (UK or US) White, Local-born (US or UK) Non-
White and Foreign-born Non-White (including individuals with and without pigmented skin of 
Indian Subcontinent and Oriental ethnicity). 
 To further compare/explore disease patterns in local-born (either UK or US) ethnic groups 
versus foreign-born ethnic groups we created a composite variable “country of birth/ethnicity” 
where we subcategorised individuals as being local/foreign-born and of different ethnic groups. 
 To investigate the effect of time since immigration on patterns of disease we also created a 
composite variable “country of birth/time since entry” as per previous authors2 which subdivided 
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individuals into local and foreign-born, with the foreign-born further subdivided by time since 
entry.  
 
 
 
Definitions of patterns of tuberculous disease 
For all datasets in our analysis, all notified TB cases (confirmed, probable or possible) which 
resulted in treatment were included. Active TB cases were initially defined by the major sites of 
disease into three distinct clinical patterns: pulmonary only (only lung parenchyma involved), 
extrapulmonary only (only one/more extrapulmonary site(s) involved) and both pulmonary and 
extrapulmonary (pulmonary disease and one/more extrapulmonary sites involved concurrently). 
This broad classification was only used to describe overall disease distribution for the Birmingham 
and US CDC cohorts. However, for the more detailed comparative analyses (such as temporal 
trends, patterns between different demographic groups and regression modelling) we adopted the 
approach taken by Peto3 and others4 5 by excluding the concurrent pulmonary and extrapulmonary 
TB category which cannot be definitively assigned to a specific category (and therefore are likely 
to result in misclassification bias). 
 Extrapulmonary sites of disease (either with or without pulmonary TB) included: 
intrathoracic lymph nodes, extrathoracic lymph nodes, bone and/or joint, central nervous system, 
pleural, peritoneal, genitourinary, intestinal, miliary, pericardial, soft tissue and other. If an 
individual had more than one extrapulmonary site involved all sites were included and therefore 
numbers would sum to greater than the total.  
 
Data analysis 
Detailed below is a more comprehensive account of the data analysis undertaken in the study. 
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Continuous data were summarised with median and interquartile range (IQR), and 
compared using the non-parametric Mann-Whitney U-test. Categorical responses were expressed 
as a simple descriptive percentage and comparisons made using Pearson’s chi-square test (or 
Fisher’s exact test if appropriate).  
 Temporal trends for main sites of disease (pulmonary only and extrapulmonary only) were 
summarised by calculating the numbers and relative proportions of each disease type for distinct 
time periods for the Birmingham (six five-yearly time intervals - 1980-1984, 1985-1989, 1990-
1994, 1995-1999, 2000-2004 and 2005-2009) and US CDC (four time intervals - 1993-1996, 1997-
2000, 2001-2004 and 2005-2008) datasets; changes in proportions over time were calculated using 
the χ2 test for trend. 
 Thereafter we calculated, and compared, the numbers (and proportion) of cases of each 
disease type stratified by local/Foreign-birth and White/Non-White ethnicity to create three main 
groups of interest: local-born White ethnicity, local-born Non-White ethnicity and foreign-born 
Non-White ethnicity. Two way comparisons were undertaken using Fisher’s exact test. In addition 
for the foreign-born (non-White) population we also examined differences in the proportion of 
cases that were pulmonary and extrapulmonary stratified by time since entry to the receiving 
country using the χ2 test for trend. Individuals who were foreign-born of White ethnicity were not 
specifically examined as they accounted for a relatively small proportion of cases in all the datasets. 
 To investigate factors associated with extrapulmonary involvement we compared 
individuals with exclusively extrapulmonary versus pulmonary patterns of disease. For the 
Birmingham dataset (but not US CDC), where individual level data was available, we undertook 
separate regression modelling for the whole cohort and for the non-White ethnic groups. 
Univariable association of factors individually associated with extrapulmonary tuberculosis only 
(compared against pulmonary cases only) was assessed using logistic regression and reported as 
crude odds ratios (OR) and 95% confidence intervals. To calculate adjusted odds ratios (and 95% 
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CI) we mutually adjusted for the following factors: year, and season, of notification, age, gender, 
ethnicity, country of birth, time since arrival and HIV status. Interaction terms (age and time since 
entry) were assessed and found to be non-significant and not included in the final multivariable 
models. For the US dataset, only aggregate data was available and therefore only univariable 
comparisons using logistic regression could be performed. 
 For the London and Leicester cohorts (analysed as one population), assessment of the 
impact of vitamin D status on disease patterns was undertaken through analysis of active TB 
patients who had serum 25-hydroxycholecalciferol [serum 25(OH)D] concentrations measured 
either before, or soon after, commencement of anti-tuberculous therapy using an immunoassay 
(Diasorin Liaison, Diosorin Ltd, Stillwater, Minnesota, USA and Centaur XP, Siemens Healthcare 
Diagnostics, New York, USA); both centres participate in the Vitamin D external equality 
assessment scheme DEQAS. The decision to measure serum 25(OH)D concentrations was 
determined by the treating physician. We used absolute serum 25-hydroxycholecalciferol 
concentrations [25(OH)D] except in individuals whose vitamin D measurement was below the 
lower limit of detection, where a value half of the lower limit was used.6 If necessary, serum 
25(OH)D concentrations were converted from µg/L to the standard nmol/L, by multiplying by 
2.496. As 25(OH)D concentrations were found to be non-normally distributed, they were log10-
transformed with geometric mean titres (and 95% confidence intervals) calculated by 
exponentiating the mean and of the lower and upper limits  of  the  95%  confidence  intervals  of  
the log10-transformed titres. Comparisons between groups were made using a one-way analysis of 
variance (on the log transformed concentrations) with Bonferroni correction, if appropriate. The 
proportions of subjects who were severely vitamin D deficient [serum 25(OH)D <20nmol/L] were 
compared between groups using Fisher’s exact test. We further assessed the factors associated with 
extrapulmonary TB in this dataset using logistic regression and reported results as odds ratios (with 
95% confidence intervals); in the multivariable model we adjusted for the centre (ie. London or 
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Leicester), year, and season, of notification, age, gender, ethnic group, location of birth, time since 
arrival, HIV status and serum 25(OH)D concentration. In the multivariable model, serum 25(OH)D 
was used as a continuous variable transformed by log2; each unit change in log2serum 25(OH)D 
corresponds to a doubling in serum 25(OH)D on the original scale which thereby allows a more 
clinically relevant, and intuitive, interpretation of the odds ratios.  For the purposes of the analysis, 
subjects with missing data were excluded on a listwise basis.
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Supplementary tables 
 
Table S1. Demographic, clinical and temporal variables associated with different patterns of tuberculosis for the whole US cohort and the Non-White ethnic groups 
 
 
Whole cohort (n=255489) 1 Non-White ethnic groups (n=196177) 1 
Variable 
 
 
Extrapulmonary  TB only 
(n=52040) 
Unadjusted OR (95% CI) 
 
p 
Variable 
 
 
Extrapulmonary  TB only 
(n=42588) 
Unadjusted OR 
(95% CI) 
 
p 
Period 
1993-1996 
1997-2000 
2001-2004 
2005-2008 
 
15253/85806 (17.8) 
13528/65930 (20.5) 
12250/54980 (22.3) 
11009/48773 (22.6) 
 
1 
1.19 (1.16-1.23) 
1.33 (1.29-1.36) 
1.35 (1.31-1.39) 
 
<0.001 
Period 
1993-1996 
1997-2000 
2001-2004 
2005-2008 
 
11642/62390 (18.7) 
10955/49774 (22) 
10425/43926 (23.7) 
9566/40087 (23.9) 
 
1 
1.23 (1.19-1.27) 
1.36 (1.32-1.40) 
1.37 (1.33-1.41) 
 
<0.001 
Age categories n (%) 
Under 5 
5-14 
15-24 
25-44 
45-64 
>64 
 
1949/9356 (20.8) 
1875/6756 (27.8) 
5034/23705 (21.2) 
19863/88342 (22.5) 
12739/70916 (18.0) 
10580/56414 (18.8) 
 
1 
1.46 (1.36-1.57) 
1.02 (0.97-1.09) 
1.10 (1.05-1.16) 
0.83 (0.79-0.88) 
0.88 (0.83-0.93) 
 
<0.001 
Age categories n (%) 
Under 5 
5-14 
15-24 
25-44 
45-64 
>64 
 
1680/8210 (20.5) 
1706/6092 (28.0) 
4678/21842 (21.4) 
17793/74678 (23.8) 
10398/52672 (19.7) 
6333/32683 (19.4) 
 
1 
1.51 (1.40-1.63) 
1.06 (1.00-1.13) 
1.22 (1.15-1.29) 
0.96 (0.90-1.01) 
0.93 (0.88-0.99) 
 
<0.001 
Gender 
Male 
Female 
 
26995/159371 (16.9) 
25045/96118 (26.1) 
 
1 
1.73 (1.69-1.76) 
 
<0.001 
Gender 
Male 
Female 
 
21607/120234 (18.0) 
20981/75943 (27.6) 
 
1 
1.74 (1.71-1.78) 
 
<0.001 
Country of birth/Ethnicity 
US-born White 
US-born American Indian 
US-born Asian 
US-born Black 
US-born Hispanic 
Foreign-born White 
Foreign-born American Indian 
Foreign-born Asian 
Foreign-born Black 
Foreign-born Hispanic 
 
7672/52022 (14.7) 
635/3079 (20.6) 
748/3010 (24.9) 
11553/65093 (17.7) 
3958/18380 (21.5) 
1780/7290 (24.4) 
26/77 (33.8) 
12994/50241 (25.9) 
4331/13680 (31.7) 
8343/42617 (19.6) 
 
1 
1.50 (1.37-1.64) 
1.91 (1.75-2.08) 
1.25 (1.21-1.29) 
1.59 (1.52-1.66) 
1.87 (1.76-1.98) 
2.95 (1.84-4.73) 
2.02 (1.95-2.08) 
2.68 (2.56-2.80) 
1.41 (1.36-1.46) 
 
<0.001 
Ethnicity 
American Indian or Alaska Native, NH 
Asian or Pacific Islander, NH 
Black or African American, NH 
Hispanic or Latino 
 
661/3156 (20.9) 
13742/53251 (25.8) 
15884/78773 (20.2) 
12301/60997 (20.2) 
 
1 
1.31 (1.20-1.43) 
0.95 (0.87-1.04) 
0.95 (0.87-1.04) 
 
 
 
 
<0.001 
Employment status 
Unemployed 
Employed  
 
25750/132732 (19.4) 
20445/92635 (22.1) 
 
1 
1.18 (1.15-1.20) 
 
 
 
<0.001 
Country of birth/time since arrival 
US-born  
Foreign-born/<1 year 
Foreign-born/1-4 years 
Foreign-born/5-14 years 
Foreign-born/≥15 years 
Foreign-born/time not known 
 
16894/89562 (18.9) 
2817/21219 (13.3) 
5947/21755 (27.3) 
6590/23851 (27.6) 
5158/20390 (25.3) 
5182/19400 (26.7) 
 
1 
0.66 (0.63-0.69) 
1.62 (1.56-1.67) 
1.64 (1.59-1.70) 
1.46 (1.41-1.51) 
1.57 (1.51-1.63) 
 
<0.001 
Previous TB 
No 
 
49779/239985 (20.7) 
 
1 
 
<0.001 
Employment status 
Unemployed 
 
20257/98781 (20.5) 
 
1 
 
<0.001 
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Yes 1803/13538 (13.3) 0.59 (0.56-0.62) Employed  17570/73625 (23.9) 1.21 (1.19-1.24) 
HIV status 
Negative 
Positive 
 
18335/94526 (19.4) 
4848/23354 (20.8) 
 
1 
1.09 (1.05-1.13) 
 Previous TB 
No 
Yes 
 
40876/184563 (22.1) 
1328/10112 (13.1) 
 
1 
0.53 (0.50-0.56) 
<0.001 
Drug sensitivity 
Not multi-drug resistant 
Multi-drug resistant 
 
34166/188723 (18.1) 
319/2869 (11.1) 
 
1 
0.57 (0.50-0.64) 
 HIV status 
Negative 
Positive 
 
38520/176150 (21.9) 
4068/20027 (20.3) 
 
1 
0.94 (0.90-0.97) 
 
0.001 
Resident in correctional facility 
No 
Yes 
 
50697/243677 (20.8) 
979/9550 (10.3) 
 
1 
0.43 (0.41-0.46) 
 Drug sensitivity 
Not multi-drug resistant 
Multi-drug resistant 
 
28112/144210 (19.5) 
269/2442 (11.0) 
 
1 
0.51 (0.45-0.58) 
 
<0.001 
   
 Resident in correctional facility 
No 
Yes 
 
41451/186698 (22.2) 
863/7840 (11.0) 
 
1 
0.43 (0.40-0.47) 
 
<0.001 
 
Footnote 
1Comparison of extrapulmonary TB cases only compared to pulmonary TB only (concurrent pulmonary-extrapulmonary cases excluded)
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Table S2. Demographic characteristics of the individuals with active TB included from the London and Leicester 
cohorts1 
 
Variable 
Subjects included in study 
 (n=462) 
Subjects excluded from the study2 
(n=263) 
p 
Age 
Median (interquartile range) 
 
 
Age categories 
16-25 
26-35 
36-45 
46-55 
over 55 
 
34 (26-47) 
 
 
 
101 (21.9%) 
144 (31.2%) 
87 (18.8%) 
63 (13.6 %) 
67 (14.5%) 
 
38 (28-53) 
 
 
 
44 (16.7%) 
68 (25.9%) 
47 (17.9%) 
48 (18.3%) 
56 (21.3%) 
 
 
 
 
 
0.03 
Gender 
Male 
Female 
 
263 (56.9%) 
199 (43.1%) 
 
131 (49.8%) 
132 (50.2%) 
 
0.06 
Ethnicity 
White 
Indian Subcontinent 
Afro-Caribbean 
Oriental/Other Asia 
Other 
 
52 (11.3%) 
276 (59.7%) 
65 (14.1%) 
64 (13.9%) 
5 (1.1%) 
 
35 (13.3%) 
136 (51.7%) 
52 (19.8%) 
37 (14.1%) 
3 (1.1%) 
 
0.21 
Place of birth3 
United Kingdom 
Foreign-born 
 
65 (14.5%) 
383 (85.5%) 
 
42 (17.0%) 
205 (83.0%) 
 
0.38 
Time since entry to the UK (years)4 
Median (interquartile range) 
 
<1 
1 - 5 
6-10 
>10 
 
7 (3-15) 
 
14 (3.8%) 
141 (38.4%) 
79 (21.5%) 
133 (36.2%) 
 
8 (4-20) 
 
7 (3.6%) 
67 (34.7%) 
47 (24.4%) 
72 (37.3%) 
 
 
 
0.80 
HIV status5 
Negative 
Positive 
 
430 (98.2%) 
8 (1.8%) 
  
200 (91.3%) 
19 (8.7%) 
 
<0.01 
 
Type of disease 
Pulmonary only 
Pulmonary and extrapulmonary 
Extrapulmonary only 
 
 
 
 
161 (34.9%) 
84 (18.2%) 
217 (47.0%) 
 
 
 
75 (28.5%) 
40 (32.3%) 
148 (56.3%) 
 
 
 
0.06 
Serum 25(OH)D (nmol/L) 
Mean (95% confidence interval) 
 
 
Vitamin D  category 
<20nmol/L 
<50nmol/L 
<75nmol/L 
 
 
12.6 (11.8-13.5) 
 
 
 
325 (70.4%) 
440 (95.2%) 
452 (97.8%) 
 
 
 
 
 
 
Footnote 
1All consecutively diagnosed cases of active TB recruited between November 1st 2007 and 30th June 2011 (for London) and January 
1st 2010 and July 10th 2012 (for Leicester) (with complete demographic and clinical data) where a serum 25(OH)D sample had been 
drawn up to 90 days prior to diagnosis or within 30 days of treatment initiation. 
2Subjects excluded due to not having had a vitamin D level checked (n=95) or the vitamin D level was done outside the pre-
specified time window (n=168) 
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3Data missing for 14 subjects included in the study and 16 subjects excluded from the study 
4Data missing for 16 subjects included in the study and 13 subjects excluded from the study  
5Data missing for 24 subjects included in the study and 44 subjects excluded from the study  
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Supplementary figures 
 
Figure S1A. Flow chart of cases included from Birmingham, UK dataset for data analysis  
 
 
 
 
 
  
10772 cases of active TB  
10152 included in analysis  
620 excluded: 
588 ethnicity not recorded 
16 site of disease not recorded 
8 country of birth not recorded 
6 age not recorded 
2 sex not recorded 
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Figure S1B. Flow chart of cases included from US Centres for Disease Control dataset for data analysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnote 
 
1Numbers sum to greater than 2429 (2573) as some individuals were excluded for more than one reason 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
279442 cases of active TB  
277013 included in analysis  
2429  excluded1: 
903 ethnicity not recorded 
95 site of disease not recorded 
1499 country of birth not 
recorded 
54 age not recorded 
22 sex not recorded 
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Figure S2. Flow chart of cases included from the London and Leicester cohorts for data analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnote 
1Individuals excluded if vitamin D sample taken more than 90 days before or 30 days after commencing 
anti-tuberculous therapy 
  
725 adults with notified 
active tuberculosis  
 
630 adults with notified 
active tuberculosis and 
25(OH) vitamin D level 
95 excluded  
25(OH)D level not done 
462 included in final analysis  
168 excluded  
25(OH) vitamin D level done 
outside pre-specified time 
window1 
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Figure S3. Proportion of individuals with pulmonary and extrapulmonary tuberculosis with different vitamin D concentrations at diagnosis 
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